Abbott Laboratories de Mexico, S.A. de C.V.
⚠️ High Risk
FEI: 3007262154 • Ciudad De Mexico, Ciudad de Mexico • MEXICO
FEI Number
3007262154
Location
Ciudad De Mexico, Ciudad de Mexico
Country
MEXICOAddress
Avenida Calzada De Tlalpan 3092, Col. Exhacienda Coapa, Coyoacan, Ciudad De Mexico, Ciudad de Mexico, Mexico
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
UNSAFE COL
The article appears to be, or to bear or contain a color additive which is unsafe within the meaning of Section 721(a).
NO ENGLISH
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).
FALSE
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(a)(1 ) of the FD&C Act in that the labeling is false or misleading in any particular.
COLOR LBLG
The article appears to contain an artificial coloring and it fails to bear labeling stating that fact.
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
LIST INGRE
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
COLORLABEL
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 11/26/2025 | 58CAY99ANTIMIGRAINE, NEC | Division of Southeast Imports (DSEI) | |
| 10/28/2024 | 61FDA56CLARITHROMYCIN (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/27/2024 | 54YGY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C. | Division of Southeast Imports (DSEI) | |
| 2/7/2023 | 61MDY41VALPROIC ACID (ANTI-CONVULSANT) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/28/2022 | 62KCA99ANTI-PERISTALTIC N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/19/2020 | 63ECA28PROPAFENONE HYDROCHLORIDE (CARDIAC DEPRESSANT (ANTI-ARRHYTHMIC)) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/3/2019 | 63ECY28PROPAFENONE HYDROCHLORIDE (CARDIAC DEPRESSANT (ANTI-ARRHYTHMIC)) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 11/16/2018 | 66SDY03BETAHISTINE HCL (VASODILATOR) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/21/2018 | 64LCK19DEXAMETHASONE (GLUCOCORTICOID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 11/30/2017 | 66JDY01LEVOTHYROXINE SODIUM (THYROID HORMONE) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/12/2017 | 64ECC02PANCREATIN (ENZYME) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/4/2017 | 66VCA99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 3/10/2017 | 61JDH09FENOFIBRATE (ANTI-CHOLESTEREMIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/6/2016 | 41GHT03ORAL REHYDRATION PRODUCTS | 75UNAPPROVED | Southwest Import District Office (SWI-DO) |
| 8/9/2016 | 66SCC03BETAHISTINE HCL (VASODILATOR) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/30/2016 | 62OCA28ENALAPRIL MALEATE (ANTI-HYPERTENSIVE - PART II) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 4/30/2016 | 65QCA44MEBEVERINE HCL (RELAXANT) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 2/23/2016 | 41GHT03ORAL REHYDRATION PRODUCTS | Southwest Import District Office (SWI-DO) | |
| 2/23/2016 | 41GHT03ORAL REHYDRATION PRODUCTS | Southwest Import District Office (SWI-DO) | |
| 2/23/2016 | 41GHT03ORAL REHYDRATION PRODUCTS | Southwest Import District Office (SWI-DO) | |
| 2/23/2016 | 41GHT03ORAL REHYDRATION PRODUCTS | Southwest Import District Office (SWI-DO) | |
| 4/9/2015 | 41GGY03ORAL REHYDRATION PRODUCTS | Southwest Import District Office (SWI-DO) | |
| 4/9/2015 | 41GGY03ORAL REHYDRATION PRODUCTS | Southwest Import District Office (SWI-DO) | |
| 4/30/2012 | 62VAF37RITONAVIR (ANTI-VIRAL) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 3/30/2012 | 62OCB13VERAPAMIL HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 11/1/2010 | 41GGT03ORAL REHYDRATION PRODUCTS | 11UNSAFE COL | Southwest Import District Office (SWI-DO) |
| 11/1/2010 | 41GGT03ORAL REHYDRATION PRODUCTS | 11UNSAFE COL | Southwest Import District Office (SWI-DO) |
| 11/1/2010 | 41GGT03ORAL REHYDRATION PRODUCTS | 11UNSAFE COL | Southwest Import District Office (SWI-DO) |
| 6/23/2009 | 41GGT03ORAL REHYDRATION PRODUCTS | Southwest Import District Office (SWI-DO) | |
| 6/23/2009 | 41GGT03ORAL REHYDRATION PRODUCTS | Southwest Import District Office (SWI-DO) | |
| 6/23/2009 | 41GGT03ORAL REHYDRATION PRODUCTS | Southwest Import District Office (SWI-DO) | |
| 5/28/2009 | 41GGT03ORAL REHYDRATION PRODUCTS | Southwest Import District Office (SWI-DO) | |
| 5/15/2009 | 41GGT03ORAL REHYDRATION PRODUCTS | 11UNSAFE COL | Southwest Import District Office (SWI-DO) |
| 4/21/2009 | 41GGT03ORAL REHYDRATION PRODUCTS | 11UNSAFE COL | Southwest Import District Office (SWI-DO) |
| 4/21/2009 | 41GGT03ORAL REHYDRATION PRODUCTS | 11UNSAFE COL | Southwest Import District Office (SWI-DO) |
| 4/21/2009 | 41GGT03ORAL REHYDRATION PRODUCTS | 11UNSAFE COL | Southwest Import District Office (SWI-DO) |
| 4/21/2009 | 41GGT03ORAL REHYDRATION PRODUCTS | 11UNSAFE COL | Southwest Import District Office (SWI-DO) |
| 2/10/2009 | 41GGT03ORAL REHYDRATION PRODUCTS | 11UNSAFE COL | Southwest Import District Office (SWI-DO) |
| 10/2/2008 | 63BAL99BRONCHODILATOR N.E.C. | New York District Office (NYK-DO) | |
| 8/20/2008 | 41GGT03ORAL REHYDRATION PRODUCTS | 274COLOR LBLG | Southwest Import District Office (SWI-DO) |
| 8/20/2008 | 41GGT03ORAL REHYDRATION PRODUCTS | 274COLOR LBLG | Southwest Import District Office (SWI-DO) |
| 2/11/2008 | 56ICL10ERYTHROMYCIN (MACROLIDES) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 7/10/2007 | 66SCA48ISOSORBIDE MONONITRATE (VASODILATOR) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 6/26/2007 | 41GGT03ORAL REHYDRATION PRODUCTS | 260FALSE | Southwest Import District Office (SWI-DO) |
| 6/26/2007 | 41GGT03ORAL REHYDRATION PRODUCTS | 260FALSE | Southwest Import District Office (SWI-DO) |
| 6/26/2007 | 41GGT03ORAL REHYDRATION PRODUCTS | 260FALSE | Southwest Import District Office (SWI-DO) |
| 6/26/2007 | 41GGT03ORAL REHYDRATION PRODUCTS | Southwest Import District Office (SWI-DO) | |
| 4/10/2007 | 41GGT03ORAL REHYDRATION PRODUCTS | 11UNSAFE COL | Southwest Import District Office (SWI-DO) |
| 11/8/2006 | 41GGT03ORAL REHYDRATION PRODUCTS | 324NO ENGLISH | Southwest Import District Office (SWI-DO) |
| 10/16/2006 | 41GGT03ORAL REHYDRATION PRODUCTS | 324NO ENGLISH | Southwest Import District Office (SWI-DO) |
| 8/24/2006 | 41GGT03ORAL REHYDRATION PRODUCTS | Southwest Import District Office (SWI-DO) | |
| 2/15/2005 | 60RCB19SIBUTRAMINE HCL MONOHYDRATE (ANOREXIC) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 3/10/2003 | 54BYL12SODIUM (MINERAL) | Southwest Import District Office (SWI-DO) | |
| 8/20/2002 | 66YBL99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C. | 75UNAPPROVED | Southwest Import District Office (SWI-DO) |
| 8/20/2002 | 66YBL99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C. | 75UNAPPROVED | Southwest Import District Office (SWI-DO) |
Frequently Asked Questions
What is Abbott Laboratories de Mexico, S.A. de C.V.'s FDA import refusal history?
Abbott Laboratories de Mexico, S.A. de C.V. (FEI: 3007262154) has 55 FDA import refusal record(s) in our database, spanning from 8/20/2002 to 11/26/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Abbott Laboratories de Mexico, S.A. de C.V.'s FEI number is 3007262154.
What types of violations has Abbott Laboratories de Mexico, S.A. de C.V. received?
Abbott Laboratories de Mexico, S.A. de C.V. has been cited for 9 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Abbott Laboratories de Mexico, S.A. de C.V. come from?
All FDA import refusal data for Abbott Laboratories de Mexico, S.A. de C.V. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.